Literature DB >> 5637562

Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine.

J I Hall, D R Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5637562      PMCID： PMC514682          DOI： 10.1136/hrt.30.1.84

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  14 in total

1.  ARRHYTHMIAS RELATED TO CARDIOVERSION.

Authors:  L LEMBERG; A CASTELLANOS; J SWENSON; A GOSSELIN
Journal:  Circulation       Date:  1964-08       Impact factor: 29.690

2.  "CARDIOVERSION" OF ARRHYTHMIAS. I.

Authors:  B LOWN
Journal:  Mod Concepts Cardiovasc Dis       Date:  1964-07

3.  MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION.

Authors:  J W HURST; E A PAULK; H D PROCTOR; R C SCHLANT
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

4.  QUINIDINE-INDUCED SYNCOPE.

Authors:  P DAVIES; D LEAK; S ORAM
Journal:  Br Med J       Date:  1965-08-28

5.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.

Authors:  B LOWN; R AMARASINGHAM; J NEUMAN
Journal:  JAMA       Date:  1962-11-03       Impact factor: 56.272

6.  THE TECHNIQUE OF CARDIOVERSION.

Authors:  B LOWN; R KLEIGER; G WOLFF
Journal:  Am Heart J       Date:  1964-02       Impact factor: 4.749

7.  Mitral stenosis diagnosis and treatment.

Authors:  A LOGAN; R TURNER
Journal:  Lancet       Date:  1953-05-30       Impact factor: 79.321

8.  The use of quinidine in established auricular fibrillation and flutter.

Authors:  D HOLZMAN; M G BROWN
Journal:  Am J Med Sci       Date:  1951-12       Impact factor: 2.378

9.  Direct current conversion of atrial fibrillation.

Authors:  P B Halmos
Journal:  Br Heart J       Date:  1966-05

10.  The use of quinidine in cardioversion.

Authors:  M Rossi; B Lown
Journal:  Am J Cardiol       Date:  1967-02       Impact factor: 2.778
View more
  12 in total

1.  Quinidine before direct current countershock. A controlled study.

Authors:  L Hillestad; J Dale; O Storstein
Journal:  Br Heart J       Date:  1972-02

2.  Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study.

Authors:  L Hillestad; C Bjerkelund; J Dale; J Maltau; O Storstein
Journal:  Br Heart J       Date:  1971-07

3.  Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate.

Authors:  E Byrne-Quinn; A J Wing
Journal:  Br Heart J       Date:  1970-05

4.  Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.

Authors:  G Härtel; A Louhija; A Konttinen; P I Halonen
Journal:  Br Heart J       Date:  1970-01

5.  Direct current shock and antidysrhythmic drugs.

Authors:  P Szekely; N A Wynne; D T Pearson; G A Batson; D A Sideris
Journal:  Br Heart J       Date:  1970-03

6.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.

Authors:  T Södermark; B Jonsson; A Olsson; L Orö; H Wallin; O Edhag; A Sjögren; M Danielsson; G Rosenhamer
Journal:  Br Heart J       Date:  1975-05

7.  Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?

Authors:  Dariusz A Kosior; Marcin Szulc; Grzegorz Opolski; Adam Torbicki; Daniel Rabczenko
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

Review 8.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

9.  Functional capacity before and after cardioversion of atrial fibrillation: a controlled study.

Authors:  A T Gosselink; H J Crijns; M P van den Berg; S A van den Broek; H Hillege; M L Landsman; K I Lie
Journal:  Br Heart J       Date:  1994-08

10.  Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors:  Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.